Challenges and Utilization of Immune Checkpoint Inhibitors in the Treatment of Lung Cancer - Quiz - MDSpire

Challenges and Utilization of Immune Checkpoint Inhibitors in the Treatment of Lung Cancer

  • By

  • Bingbing Li

  • Yuning Ren

  • Xiaoling Zhang

  • April 20, 2026

  • 0 min

Share

Original Source(s)

Challenges and Utilization of Immune Checkpoint Inhibitors in the Treatment of Lung Cancer

  • by Bingbing Li, Yuning Ren, Xiaoling Zhang

  • April 20, 2026

Related Content

Research progress in imaging detection of brain metastases

Development of a CT-based comprehensive model with deep learning for differentiating pathological types of pulmonary ground-glass nodules

Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cells